Effects of gambogic acid on the activation of caspase-3 and downregulation of SIRT1 in RPMI-8226 multiple myeloma cells via the accumulation of ROS

By              

Oncology Letters, Vol. 3, Iss. 5, 2012-01 ,pp. : 1159-1165

Spandidos Publications

Access to resources Recommend Favorite

Dyclonine enhances the cytotoxic effect of proteasome inhibitor bortezomib in multiple myeloma cells

By    

Molecular Medicine Reports, Vol. 10, Iss. 5, 2014-01 ,pp. : 2609-2612

Spandidos Publications

Access to resources Recommend Favorite

Imexon-based combination chemotherapy in A375 human melanoma and RPMI 8226 human myeloma cell lines

By Scott Julie   Dorr Robert   Samulitis Betty   Landowski Terry  

Cancer Chemotherapy and Pharmacology, Vol. 59, Iss. 6, 2007-06 ,pp. : 749-757

Springer Publishing Company

Access to resources Recommend Favorite

Cyclooxygenase-2 Inhibitor NS398 Enhances Radiosensitivity of Radioresistant Esophageal Cancer Cells by Inhibiting AKT Activation and Inducing Apoptosis

By Che Shao-Min   Zhang Xiao-Zhi   Hou Lei   Song Tian-Bao  

Cancer Investigation, Vol. 28, Iss. 7, 2010-07 ,pp. : 679-688

Informa Healthcare

Access to resources Recommend Favorite

PJ34, a poly(ADP-ribose) polymerase (PARP) inhibitor, reverses melphalan-resistance and inhibits repair of DNA double-strand breaks by targeting the FA/BRCA pathway in multidrug resistant multiple myeloma cell line RPMI8226/R

By  

International Journal of Oncology, Vol. 46, Iss. 1, 2015-01 ,pp. : 223-232

Spandidos Publications

Access to resources Recommend Favorite